Measuring Hearing Health in Head and Neck Cancer Patients During Treatment
NCT06662058 · RecruitingThis clinical trial looks at how offering hearing tests close to home can help patients with head and neck squamous cell cancer. These patients receive a chemotherapy called cisplatin or radiation, which can sometimes cause hearing loss. The goal is to see if more patients participate in monitoring their hearing when tests are more accessible. Detecting changes in hearing can help doctors make adjustments to treatments to protect hearing quality.
Locations and contact
This trial is running at 1 location in the United States. It is currently recruiting.
United States1 location · 1 recruiting
- Emory Midtown University Hospital/Winship Cancer InstituteAtlanta, GeorgiaRecruiting
Who can join
Adults aged 18 and older can join this trial. It is open to both men and women with certain types of head and neck cancer. Participants must be able to give consent and will receive cisplatin and/or radiation. However, those with severe hearing loss or who cannot take a hearing test cannot join. The trial team will confirm if you can participate.
What happens during the trial
Participants are randomly placed into one of two groups. In one group, patients will have hearing tests at a specific location before treatment and at 3 and 12 months after. In the other group, patients who live far away or have advanced cancer can choose to have tests closer to home or do remote tests at those same time points after treatment.
The trial team
The trial is led by Emory University, with Dr. Nicole C Schmitt as the principal investigator. It also collaborates with the National Cancer Institute and the National Institute on Deafness and Other Communication Disorders.
Important dates
The trial started on March 12, 2025, and is expected to finish by October 31, 2029. It is currently enrolling new participants.
Additional information
This trial is registered under NCT06662058. It does not involve any FDA-regulated drugs or devices. The trial plans to include 118 participants.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →